comparemela.com

Latest Breaking News On - Newman dignan sheerar inc - Page 12 : comparemela.com

Newman Dignan & Sheerar Inc Has $2 21 Million Position in Quanta Services, Inc (NYSE:PWR)

Newman Dignan & Sheerar Inc. reduced its stake in Quanta Services, Inc. (NYSE:PWR – Free Report) by 4.5% during the third quarter, HoldingsChannel reports. The firm owned 11,795 shares of the construction company’s stock after selling 550 shares during the quarter. Newman Dignan & Sheerar Inc.’s holdings in Quanta Services were worth $2,207,000 at the […]

Newman Dignan & Sheerar Inc Decreases Stock Position in Roper Technologies, Inc (NYSE:ROP)

Newman Dignan & Sheerar Inc. cut its holdings in Roper Technologies, Inc. (NYSE:ROP – Free Report) by 3.5% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,704 shares of the industrial products company’s stock after selling 61 shares during the period. Newman […]

Newman Dignan & Sheerar Inc Raises Holdings in Schwab US Broad Market ETF (NYSEARCA:SCHB)

Newman Dignan & Sheerar Inc. boosted its stake in shares of Schwab US Broad Market ETF (NYSEARCA:SCHB – Free Report) by 18.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,366 shares of the company’s stock after acquiring an additional 2,899 shares during […]

Newman Dignan & Sheerar Inc Has $1 27 Million Holdings in Fiserv, Inc (NASDAQ:FISV)

Newman Dignan & Sheerar Inc. cut its stake in shares of Fiserv, Inc. (NASDAQ:FISV – Free Report) by 3.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,223 shares of the company’s stock after selling 352 shares during the period. Newman Dignan & Sheerar […]

Newman Dignan & Sheerar Inc Has $1 18 Million Stake in Bristol-Myers Squibb (NYSE:BMY)

Newman Dignan & Sheerar Inc. decreased its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,388 shares of the biopharmaceutical company’s stock after selling 1,006 shares during the quarter. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.